R R

What Is a Clotting Factor Concentrate?

A clotting factor concentrate is a purified or manufactured preparation containing one or more proteins needed for blood coagulation. It replaces or supplements a factor that is missing, reduced, or not working properly. Products can be derived from donated human plasma or produced through recombinant technology. The exact concentrate is selected according to the bleeding disorder, factor level, inhibitors, and clinical situation.

Link to This Resource Page

Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.

To display this...

What Is a Clotting Factor Concentrate?

A clotting factor concentrate is a purified or manufactured preparation containing one or more proteins needed for blood coagulation. It replaces or supplements a factor that is missing, reduced, or not working properly. Products can be derived from donated human plasma or produced through recombinant technology. The exact concentrate is selected according to the bleeding disorder, factor level, inhibitors, and clinical situation.

read more about clotting factor concentrate ...

Copy this HTML:

Copy HTML Copied!

What Are Clotting Factor Concentrates Used For?

Clotting factor concentrates are used to prevent or control bleeding in inherited and acquired coagulation disorders. Factor VIII products treat hemophilia A, while factor IX products treat hemophilia B. Other concentrates can contain von Willebrand factor, fibrinogen, factor XIII, or several vitamin K-dependent factors. They can be used for routine prophylaxis, treatment of an active bleed, or bleeding prevention around surgery.

What Types of Clotting Factor Concentrates Are There?

Single-factor concentrates replace a specific deficient protein, such as factor VIII or factor IX. Prothrombin complex concentrates contain several vitamin K-dependent clotting factors and are used in selected urgent reversal or deficiency settings. Some products are plasma derived, while recombinant products are made without using human plasma as the source of the therapeutic factor. Extended-half-life products are modified to remain active in circulation longer.

How Are Clotting Factor Concentrates Given?

Most clotting factor concentrates are reconstituted from powder and administered through a vein. The dose and schedule depend on body weight, measured factor activity, bleeding severity, treatment goal, and product characteristics. Some patients or caregivers learn home infusion for prophylaxis or early treatment of bleeding. Factor levels, bleeding response, and development of neutralizing antibodies can require monitoring.

What Are the Side Effects and Precautions?

Possible effects include headache, fever, nausea, infusion reactions, and hypersensitivity. Some patients develop inhibitors that neutralize the replacement factor and reduce treatment effectiveness. Products containing several coagulation factors can increase the risk of thrombosis in susceptible patients or when used excessively. Plasma-derived products undergo donor screening and pathogen-reduction steps, but product-specific infection and safety information must still be reviewed.

Frequently Asked Questions About Clotting Factor Concentrates

Are clotting factor concentrates made from blood?

Some are purified from donated human plasma, while others are produced through recombinant technology. The source and manufacturing process are listed in the product information.

What is a clotting factor inhibitor?

It is an antibody that neutralizes a clotting factor or its replacement product. Inhibitors can make standard factor treatment less effective and require specialized management.

Can clotting factor concentrate prevent bleeding?

Yes. Regular prophylactic infusions can maintain factor activity and reduce bleeding frequency in selected disorders. The schedule depends on the factor deficiency and product.

Is prothrombin complex concentrate a clotting factor concentrate?

Yes. Prothrombin complex concentrate contains multiple vitamin K-dependent factors. It is used for specific indications, including selected urgent anticoagulant-reversal situations.

References

WFH Guidelines for the Management of Hemophilia, 3rd Edition. World Federation of Hemophilia. https://www1.wfh.org/publications/files/pdf-1863.pdf. Date Accessed August 6, 2026.

Treatment of Hemophilia. Centers for Disease Control and Prevention. https://www.cdc.gov/hemophilia/treatment/index.html. Date Accessed August 6, 2026.

Hemophilia. StatPearls (NCBI Bookshelf). https://www.ncbi.nlm.nih.gov/books/NBK551607/. Date Accessed August 6, 2026.

Von Willebrand Factor. StatPearls (NCBI Bookshelf). https://www.ncbi.nlm.nih.gov/books/NBK565885/. Date Accessed August 6, 2026.

KCENTRA (Prothrombin Complex Concentrate [Human]): Prescribing Information. U.S. Food and Drug Administration. https://www.fda.gov/media/85512/download. Date Accessed August 6, 2026.